Eastman Chemical (EMN) Could Be 13% Undervalued Following Its $300 Million Note Offering
Alpha Vantage · Simply Wall St · · AI-summarised by FinFlash
Eastman Chemical (EMN) recently issued US$300 million in 5.500% senior unsecured notes, a move that provides new insight into its funding strategy. Despite a recent 1-month share price rebound, the company is trading significantly below analyst targets and intrinsic value estimates, with Simply Wall St's consensus suggesting it is 13% undervalued at a fair value of $74.81.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.